BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24498180)

  • 1. A novel acylaminoimidazole derivative, WN1316, alleviates disease progression via suppression of glial inflammation in ALS mouse model.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Inoue S; Hirayama N; Ikeda JE
    PLoS One; 2014; 9(1):e87728. PubMed ID: 24498180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1
    Chiarotto GB; Cartarozzi LP; Perez M; Biscola NP; Spejo AB; Gubert F; França Junior M; Mendez-Otero R; de Oliveira ALR
    J Neuroinflammation; 2019 Nov; 16(1):218. PubMed ID: 31727149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
    J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection.
    Kanno T; Yasutake K; Tanaka K; Hadano S; Ikeda JE
    PLoS One; 2017; 12(10):e0186227. PubMed ID: 29016670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1
    Zhou QM; Zhang JJ; Li S; Chen S; Le WD
    CNS Neurosci Ther; 2017 May; 23(5):375-385. PubMed ID: 28229532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
    Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
    PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor antagonism accelerates disease onset in the SOD1
    McLeod VM; Lau CL; Chiam MDF; Rupasinghe TW; Roessner U; Djouma E; Boon WC; Turner BJ
    Br J Pharmacol; 2019 Jul; 176(13):2111-2130. PubMed ID: 30849180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis.
    Pollari E; Savchenko E; Jaronen M; Kanninen K; Malm T; Wojciechowski S; Ahtoniemi T; Goldsteins G; Giniatullina R; Giniatullin R; Koistinaho J; Magga J
    J Neuroinflammation; 2011 Jun; 8():74. PubMed ID: 21711557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics analysis indicates the involvement of immunity and inflammation in the onset stage of SOD1-G93A mouse model of ALS.
    Chen L; Wang N; Zhang Y; Li D; He C; Li Z; Zhang J; Guo Y
    J Proteomics; 2023 Feb; 272():104776. PubMed ID: 36423857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1
    Mitsui S; Otomo A; Nozaki M; Ono S; Sato K; Shirakawa R; Adachi H; Aoki M; Sobue G; Shang HF; Hadano S
    Mol Brain; 2018 May; 11(1):30. PubMed ID: 29843805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.
    Kato S; Kato M; Abe Y; Matsumura T; Nishino T; Aoki M; Itoyama Y; Asayama K; Awaya A; Hirano A; Ohama E
    Acta Neuropathol; 2005 Aug; 110(2):101-12. PubMed ID: 15983830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.